Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update

Search Results for "TTP":

Results: 255

Quotes

TTP Tortoise Pipeline And Energy Closed Fund Stock - NYSE equities TTP TD S&P/TSX Capped Composite ETF - Toronto etf TTP Tatepa Ltd Stock - Dar Es Salaam equities TTP Tan Tien Plastic Packaging JSC Stock - Hanoi equities TTP TD S&P/TSX Capped Composite ETF - CBOE Canada etf TTPW Tata Power Co. Ltd Stock - NSE equities TTPWc1:NS Tata Power Ltd Future Stock Future - NSE equities TTPW Tata Power Co. Ltd Stock - BSE equities
Show all (12)

News

Autohome Inc. Announces Unaudited First Quarter 2024 Financial Results
By Investing.com

BEIJING, May 8, 2024 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced its...

CrowdStrike Delivers the Next Generation of SIEM to Power the AI-Native SOC
By Investing.com

Falcon Next-Gen SIEM innovations modernize SOC operations with a single, unified platform to deliver full visibility and protection across all workloads; Falcon Insight customers receive 10 gigabytes...

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
By Investing.com

Continuous blood glucose monitor's preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc....

Show all (208)

Analysis

The Futures Market’s Darkest Day: PFG Collapse
By James Bibbings

Over the last twenty four hours the futures industry was roiled by another clearing firm collapse. For those of you who have not yet heard, Peregrine Financial Group (“PFG”), was shuttered Monday....

ArQule Shares Bottom Out After Encouraging ASCO Data
By Myriad Equity

ArQule (ARQL) is a drug developer with a market cap of about $340 million. It has a pipeline containing five separate drugs. The most important of these (to investors) is tivantinib (ARQ 197), which...

ArQule Shares Bottom Out After Encouraging ASCO Data
By Myriad Equity

ArQule (ARQL) is a drug developer with a market cap of about $340 million. It has a pipeline containing five separate drugs. The most important of these (to investors) is tivantinib (ARQ 197), which...

Show all (35)
Results: 12

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 208

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 35

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email